1. Yang, Lu-Lu, Xiao, Wen-Chang, Li, Huan, Huang, Zhen, Zhang, Yan-Zhou. 2022. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING. In Cell death & disease, 13, 889. doi:10.1038/s41419-022-05231-8. https://pubmed.ncbi.nlm.nih.gov/36270989/
2. Khateb, Ali, Deshpande, Anagha, Feng, Yongmei, Deshpande, Aniruddha J, Ronai, Ze'ev A. 2021. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. In Nature communications, 12, 5397. doi:10.1038/s41467-021-25664-7. https://pubmed.ncbi.nlm.nih.gov/34518534/
3. Principi, Elisa, Sondo, Elvira, Bianchi, Giovanna, Pedemonte, Nicoletta, Raffaghello, Lizzia. 2022. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors. In Cancers, 14, . doi:10.3390/cancers14071802. https://pubmed.ncbi.nlm.nih.gov/35406574/
4. Zhong, Bo, Zhang, Lu, Lei, Caoqi, Zhang, Xiao-Lian, Shu, Hong-Bing. 2009. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. In Immunity, 30, 397-407. doi:10.1016/j.immuni.2009.01.008. https://pubmed.ncbi.nlm.nih.gov/19285439/
5. Wei, Guanxin, Chen, Xiang, Ruan, Tuo, Tao, Kaixiong, Wu, Chuanqing. 2024. Human gastric cancer progression and stabilization of ATG2B through RNF5 binding facilitated by autophagy-associated CircDHX8. In Cell death & disease, 15, 410. doi:10.1038/s41419-024-06782-8. https://pubmed.ncbi.nlm.nih.gov/38866787/
智鼠故事 
